Trade AbbVie ^ABBV

Meeder Asset Management Inc. Trims Stock Position in AbbVie Inc. $ABBV - Markets Daily

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $14.71 Million Stock Holdings in AbbVie Inc. $ABBV

AbbVie to License RemeGen Cancer Drug | Morningstar

Meeder Asset Management Inc. Trims Stake in AbbVie Inc. $ABBV

Tema Etfs LLC Grows Stock Holdings in AbbVie Inc. $ABBV

AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors

AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States

Citizens Financial Group Inc. RI Grows Stake in AbbVie Inc. $ABBV

Tema Etfs LLC Raises Holdings in AbbVie Inc. $ABBV - Stock Observer

West To Sell SmartDose 3.5mL On-Body Delivery System To AbbVie For $112.5 Mln

AbbVie Inc. $ABBV Shares Acquired by Sumitomo Mitsui Trust Group Inc. - Daily Political

Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

REGENXBIO Highlights Key 2026 Catalysts and Announces Positi

AbbVie Inc. $ABBV Shares Sold by New York State Teachers Retirement System

AbbVie Inc. $ABBV Shares Bought by Legacy Trust - Markets Daily

AbbVie Inc. $ABBV Stake Raised by Associated Banc Corp

AbbVie Inc. $ABBV Shares Acquired by Legacy Trust - Stock Observer

Oliver Luxxe Assets LLC Acquires 2,517 Shares of AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research

AbbVie Inc. $ABBV Shares Bought by Rede Wealth LLC

Revolution Medicines (NASDAQ:RVMD) CFO Jack Anders Sells 10,000 Shares - Stock Observer

AbbVie (NYSE:ABBV) Shares Down 1.8% - Here's Why

STAT's Adam Feuerstein says Revolution Medicines canceled meeting | Markets Insider

What Catalysts Could Shift AbbVie's Story As Analysts Rework Targets And Drug Expectations

Oregon Public Employees Retirement Fund Has $46.75 Million Position in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Holdings Decreased by State of Alaska Department of Revenue

Nisa Investment Advisors LLC Boosts Holdings in AbbVie Inc. $ABBV - Markets Daily

Revolution Medicines (NASDAQ:RVMD) Reaches New 12-Month High - Still a Buy? - Markets Daily

AbbVie Inc. $ABBV Shares Bought by Duncker Streett & Co. Inc.

AbbVie Inc. $ABBV Stake Raised by Oregon Public Employees Retirement Fund - Stock Observer

AbbVie Inc. $ABBV Shares Acquired by Capital Investment Advisors LLC

Is AbbVie (ABBV) Still Attractive After Strong 1-Year And 5-Year Share Price Gains?

AbbVie (NYSE:ABBV) Updates FY 2025 Earnings Guidance - Stock Observer

ABBV: Future Returns Will Depend On Post-Humira Immunology And Pipeline Execution

An updated definition of freezing of gait

Health Care Down Amid Deal Skepticism - Health Care Roundup | Morningstar

AbbVie (NYSE:ABBV) Trading Down 3.9% - Here's Why

Traders Purchase High Volume of Call Options on Revolution Medicines (NASDAQ:RVMD) - Markets Daily

AbbVie Flags $1.3B Charge, Cuts Fourth-Quarter EPS Outlook

Legacy CG LLC Buys 14,257 Shares of AbbVie Inc. $ABBV

AbbVie (ABBV) Stock Falls After Company Denies Revolution Medicines Buyout Talks

Investors Purchase Large Volume of Call Options on Revolution Medicines (NASDAQ:RVMD) - Stock Observer

AbbVie Inc. $ABBV Stock Position Increased by HB Wealth Management LLC

AbbVie (NYSE:ABBV) Issues FY 2025 Earnings Guidance

AbbVie (NYSE:ABBV) Releases Q4 2025 Earnings Guidance

AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.73

AbbVie Inc. $ABBV Stock Holdings Increased by CX Institutional

AbbVie Denies Acquisition Talks with Revolution Medicines Amid Stock Volatility, ETPharma

Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

AbbVie (NYSE:ABBV) Shares Up 4.3% - What's Next?

AbbVie Says It's Not in Talks to Buy Revolution Medicines (1)

AbbVie denies media reports of talks to buy Revolution Medicines

Dow Jones Top Company Headlines at 3 PM ET: AbbVie Near Deal for Revolution Medicines | Anthropic ... | Morningstar

AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.73

Securian Asset Management Inc. Sells 7,037 Shares of AbbVie Inc. $ABBV - Markets Daily

KLP Kapitalforvaltning AS Has $172.38 Million Stake in AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Stake Boosted by Park Avenue Securities LLC

AbbVie Inc. $ABBV Shares Purchased by KLP Kapitalforvaltning AS

Sivik Global Healthcare LLC Takes Position in AbbVie Inc. $ABBV

AbbVie to Host Full-Year and Fourth-Quarter 2025 Earnings Conference Call

Assessing AbbVie (ABBV) Valuation After Recent Share Price Gain And Mixed Return Profile

AbbVie Inc. $ABBV Shares Acquired by Cerity Partners LLC

AbbVie Inc. $ABBV Stock Holdings Increased by Capital & Planning LLC

AbbVie Inc Stock Live Price, Chart, Analysis, News & Forecast - Buy, Sell & Trade US Equities Today

Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis

AbbVie (NYSE:ABBV) Stock Price Up 1.7% - Still a Buy?

AbbVie Inc. $ABBV Shares Bought by Spirepoint Private Client LLC

Greenleaf Trust Sells 28,666 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Holdings Lifted by Torray Investment Partners LLC

MAVIRET® receives Health Canada Approval for the Treatment of Acute Hepatitis C Virus

AbbVie Inc. $ABBV Shares Purchased by Sitrin Capital Management LLC

Will AbbVie's (ABBV) Zelgen Lung Cancer Deal Reshape Its Post‑Humira Resilience Narrative?

Torray Investment Partners LLC Has $23.53 Million Stake in AbbVie Inc. $ABBV - Stock Observer

Geneos Wealth Management Inc. Cuts Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Stock Price Down 3.8% - Time to Sell?

Promising Pharmaceutical Stocks To Follow Now - January 5th - Markets Daily

Assessing AbbVie (ABBV) Valuation After Strong Multi‑Year Shareholder Returns

Railway Pension Investments Ltd Raises Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Holdings Raised by CWA Asset Management Group LLC

Commonwealth Equity Services LLC Cuts Holdings in AbbVie Inc. $ABBV

Asset Management One Co. Ltd. Raises Holdings in AbbVie Inc. $ABBV

Is AbbVie (ABBV) Still Attractively Priced After A 31.8% One Year Gain?

AbbVie Inc. $ABBV Holdings Lifted by Capital Advisors Inc. OK

Davis Capital Management Purchases New Stake in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Acquired by Gateway Investment Advisers LLC - Stock Observer

AbbVie (NYSE:ABBV) Downgraded by Wall Street Zen to Buy - Daily Political

Analysts' Downgrades for January 3rd (ABBV, ACAD, ACLS, AFRM, ARI, ARLP, AROW, ASAN, ASB, AUGO) - Markets Daily

Pharmaceutical Stocks To Keep An Eye On - January 3rd - Stock Observer

PICTET BANK & TRUST Ltd Invests $1.61 Million in AbbVie Inc. $ABBV

First Pacific Financial Increases Stock Holdings in AbbVie Inc. $ABBV

SteelPeak Wealth LLC Has $5.98 Million Position in AbbVie Inc. $ABBV

Bell Bank Sells 10,943 Shares of AbbVie Inc. $ABBV

Altfest L J & Co. Inc. Has $5.90 Million Stake in AbbVie Inc. $ABBV

First Pacific Financial Boosts Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Downgraded to "Buy" Rating by Wall Street Zen

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: Growth, Inflation, and Consumer Trends in Focus

Week Ahead: China Is On Holiday, But The BoC, The Fed, And The ECB Will Be Busy With The First 2025 Rate Announcements 

Week ahead: Magnificent 7 earnings, 2 key inflation reports

Week ahead: Earnings bonanza, ECB decision & US inflation

Week ahead: Fed, ECB & BoJ in action

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk